Nogo receptor 1 expression in glioblastoma modulates myelin-associated infiltration

Takeaway

  • Nogo receptor 1 (NgR1) is involved in suppressing myelin-associated infiltration in glioblastoma (GBM) and low NgR1 expression was associated with poor clinical outcomes in patients with GBM. In a mouse model of GBM, pimozide treatment increased NgR1 expression and reduced infiltration in tumor tissue.

Why this matters

    In GBM, the most aggressive primary brain tumor, cells have the ability to invade brain structures using myelinated axon fibers as one of the main migratory routes. Enhancing the understanding of the molecular mechanisms underlying myelin-associated infiltration of GBM cells may reveal novel therapeutic targets for treatment of patients with GBM.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.